Rakes G P, Arruda E, Ingram J M, Hoover G E, Zambrano J C, Hayden F G, Platts-Mills T A, Heymann P W
Departments of Pediatrics, Internal Medicine, and Pathology, University of Virginia Health Sciences Center, Charlottesville, USA.
Am J Respir Crit Care Med. 1999 Mar;159(3):785-90. doi: 10.1164/ajrccm.159.3.9801052.
This cross-sectional emergency department study of 70 wheezing children and 59 control subjects (2 mo to 16 yr of age) examined the prevalence of respiratory viruses and their relationship to age, atopic status, and eosinophil markers. Nasal washes were cultured for respiratory viruses, assayed for respiratory syncytial virus (RSV) antigen, and tested for coronavirus and rhinovirus RNA using reverse transcription-PCR (RT-PCR). Also evaluated were eosinophil numbers and eosinophil cationic protein (ECP) in both nasal washes and serum, along with total IgE and specific IgE antibody in serum. Respiratory viruses were detected in 82% (18 of 22) of wheezing infants younger than 2 yr of age and in 83% (40 of 48) of older wheezing children. The predominant pathogens were RSV in infants (detected in 68% of wheezing subjects) and rhinovirus in older wheezing children (71%), and both were strongly associated with wheezing (p < 0.005). RSV was largely limited to wheezing children younger than 24 mo of age, but rhinovirus was detected by RT-PCR in 41% of all infants and in 35% of nonwheezing control subjects older than 2 yr of age. After 2 yr of age the strongest odds for wheezing were observed among those who had a positive RT-PCR test for rhinovirus together with a positive serum radioallergosorbent testing (RAST), nasal eosinophilia, or elevated nasal ECP (odds ratios = 17, 21, and 25, respectively). Results from this study demonstrate that a large majority of emergent wheezing illnesses during childhood (2 to 16 yr of age) can be linked to infection with rhinovirus, and that these wheezing attacks are most likely in those who have rhinovirus together with evidence of atopy or eosinophilic airway inflammation.
这项针对70名喘息儿童和59名对照受试者(2个月至16岁)的横断面急诊科研究,调查了呼吸道病毒的患病率及其与年龄、特应性状态和嗜酸性粒细胞标志物的关系。对鼻洗液进行呼吸道病毒培养、呼吸道合胞病毒(RSV)抗原检测,并使用逆转录聚合酶链反应(RT-PCR)检测冠状病毒和鼻病毒RNA。同时还评估了鼻洗液和血清中的嗜酸性粒细胞数量及嗜酸性粒细胞阳离子蛋白(ECP),以及血清中的总IgE和特异性IgE抗体。在2岁以下的喘息婴儿中,82%(22例中的18例)检测到呼吸道病毒,在年龄较大的喘息儿童中,83%(48例中的40例)检测到呼吸道病毒。主要病原体在婴儿中是RSV(在68%的喘息受试者中检测到),在年龄较大的喘息儿童中是鼻病毒(71%),两者均与喘息密切相关(p<0.005)。RSV主要局限于24个月以下的喘息儿童,但通过RT-PCR在所有婴儿的41%和2岁以上非喘息对照受试者的35%中检测到鼻病毒。2岁以后,在鼻病毒RT-PCR检测呈阳性且血清放射性变应原吸附试验(RAST)呈阳性、鼻嗜酸性粒细胞增多或鼻ECP升高的人群中,观察到喘息的几率最高(优势比分别为17、21和25)。这项研究的结果表明,儿童期(2至16岁)绝大多数紧急喘息疾病可与鼻病毒感染相关,并且这些喘息发作最可能发生在同时感染鼻病毒且有特应性或嗜酸性气道炎症证据的人群中。